AMAG Pharmaceuticals Up 14% (AMAG)

AMAG Pharmaceuticals, Inc. AMAG is up sharply this morning, gaining more than 14% on back of news that it came to an agreement with the FDA over labeling of its Feraheme injection drug. AMAG has agreed to a label that includes warnings about potentially life-threatening events, but avoided a boxed warning, or "black box" label. This story was first mentioned in Barron's.